Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
about
Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injuryMechanisms of Action of Antiseizure Drugs and the Ketogenic DietNovel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)Review of topiramate for the treatment of epilepsy in elderly patients.Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implicationsTopiramate: a review of analytical approaches for biological matrices.Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.Phentermine and topiramate for the management of obesity: a review.Topiramate: safety and efficacy of its use in the prevention and treatment of migraine.Topiramate-induced maculopathy in IgG4-related disease.The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memoryTopiramate in migraine progression.Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.Neurological perspectives on voltage-gated sodium channels.Chronic migraine - new treatment options.Combination phentermine and topiramate extended release in the management of obesity.Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations.Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.Topiramate in Migraine Prevention: A 2016 Perspective.Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.Comparative Pre-Emptive Analgesic Efficacy Study of Novel Antiepileptic Agents Lamotrigine and Topiramate in Patients Undergoing Major Surgeries at a Tertiary Care Hospital: A Randomized Double Blind Clinical Trial.Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.'Possessed': acute confusional migraine in an adolescent, prevented by topiramate.Topiramate-antagonism of L-glutamate-induced paroxysms in planarians.Chronic Cellular Hyperexcitability in Elderly Epileptic Rats with Spontaneous Seizures Induced by Kainic Acid Status Epilepticus while Young Adults.Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness.Topiramate as a neuroprotective agent in a rat model of spinal cord injury.Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes.Effects of selenium and topiramate on cytosolic Ca(2+) influx and oxidative stress in neuronal PC12 cells.
P2860
Q27306821-4FCC0054-09DF-4226-A167-9EED0659B26FQ28272457-F5A09709-42C5-4D2C-A457-44488610908FQ30577314-30B0A6E1-5E63-4BB3-B95C-97FD46271C16Q33819386-E779ECF6-7B09-4AC5-B374-7374C9CE15C6Q35023333-6F6CFA01-94C7-4304-8257-8F1944D59DDEQ35601185-1AF7F929-0EE8-44D0-BCF7-FA51A0324030Q36252863-3943F929-2339-4237-910A-7B76C6BCEC51Q36758207-2981AE61-5A35-49F3-8B2D-BA3E08CD5D84Q36873926-C326DEAE-98E7-49FE-AAEC-6C2A42FA6E32Q37007272-05583154-0970-4444-AF7E-3DBDBA74A768Q37244159-A5293202-1C46-4EC5-8F9D-F367DD6BE3E7Q37617133-5CE82C60-E731-4790-B02B-29DC417F3F4AQ38028609-60487620-3DD1-40F9-94E6-F9D7BBA9890FQ38042001-0B45DBD2-FA5D-48CE-80DC-75AE204B6C6DQ38364187-6A52E59E-58D6-4A8E-9167-FAC0EA84E6CDQ38469824-E1388F5A-CFE0-4DD9-B7E9-7FA70454E7D2Q38567300-35EAA6C6-A970-49E1-816A-5665C791A576Q38812405-72A1B4DC-527D-4A23-99DE-4FB93D65FD9FQ39024628-95528AE8-9E5F-4D34-91DB-EEC6E72C5519Q39256375-941D3F77-5BA4-4261-80FF-4D193042AB0DQ39307501-669D2202-0DAF-4416-A40D-5EA975A6E8EAQ40267874-301847B2-2949-48A2-B43B-EE9B080E0867Q42018697-C3396FCB-5114-45B4-8635-1BE1392F66FEQ42380517-B9CD597F-75D9-4819-A461-A25AEE3EB32DQ42597828-E17886DB-DB32-463F-97C4-A40BB5FAA49FQ47656495-BEF9CC98-F854-40E9-ABA3-1C40F4E2C7F9Q47870774-4AEE8ADB-B3EF-4412-A13B-4174F11380C2Q47898735-DA760C7F-286D-4A2D-9A0E-5EFE270BC2DCQ53143274-B0D9FB9B-A68B-47CF-82A3-792CA3F8BCEF
P2860
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
@en
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
@nl
type
label
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
@en
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
@nl
prefLabel
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
@en
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
@nl
P2860
P1476
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
@en
P2093
Bruce E Maryanoff
Richard P Shank
P2860
P304
P356
10.1111/J.1527-3458.2008.00041.X
P577
2008-01-01T00:00:00Z